Syndrome

AI-driven model enhances treatment decisions for cancer patients after heart attack

by

The Future of Heart Attack Care: Personalizing Treatment for Cancer Patients For decades, cancer patients experiencing heart attacks have been a uniquely vulnerable population, often excluded from vital research and lacking tailored treatment guidelines. This is changing. A groundbreaking new risk prediction model, ONCO-ACS, developed by an international team led by the University of Zurich, … Read more

Targeted uterine mRNA treatment boosts fertility outcomes in mice

by

Revolutionizing Infertility Treatment: mRNA Nanoparticles Offer New Hope For millions struggling with infertility, the path to parenthood is often fraught with challenges. Now, groundbreaking research from Johns Hopkins Medicine is offering a beacon of hope, utilizing the power of messenger RNA (mRNA) delivered via precisely engineered nanoparticles. This isn’t just incremental progress; it’s a potential … Read more

TGM2 as a novel biomarker for acute myocardial infarction and prognosis in acute coronary syndrome

by

New Biomarker on the Horizon? How Transglutaminase 2 Could Revolutionize Heart Attack Prediction A recent study published in Cardiovascular Innovations and Applications is turning heads in the cardiology world. Researchers have uncovered a strong link between levels of a protein called Transglutaminase 2 (TGM2) and the severity of heart attacks, potentially paving the way for … Read more

Tracing the decline in American heart disease mortality

by

Heart Disease & Stroke: A Declining Threat, But a Persistent Danger – What the Future Holds After a five-year surge likely fueled by the disruptions of the COVID-19 pandemic, deaths from heart disease and stroke are finally showing a decline. However, these conditions remain the leading causes of death in the United States, claiming more … Read more

COVID-19 severity is linked to changes in mitochondrial DNA methylation

by

COVID-19’s Hidden Impact: How Mitochondrial Changes Could Shape Future Treatments New research is shedding light on a critical, often overlooked aspect of severe COVID-19: disruptions in mitochondrial function. A recent study focusing on Indian patients reveals distinct methylation signatures within mitochondria – the powerhouses of our cells – and alterations in mitochondrial proteins. This isn’t … Read more

Genomic screening uncovers hidden cancer and heart disease risk in young adults

by

The Dawn of Predictive Healthcare: How Genomic Screening is Rewriting the Rules of Wellness For decades, genetic testing has largely been reactive – a tool used to diagnose existing conditions or assess risk based on family history. But a groundbreaking Australian pilot program, recently published in Nature Health, is signaling a dramatic shift. It demonstrates … Read more

PFAS exposure increases gestational diabetes risk

by

“Forever Chemicals” and Diabetes: What the Latest Research Means for Your Health A growing body of evidence is linking exposure to per- and polyfluoroalkyl substances (PFAS) – often called “forever chemicals” – to an increased risk of diabetes, particularly gestational diabetes. A recent meta-analysis of nearly 130 studies, published in eClinicalMedicine, provides the strongest evidence … Read more

Light daily movement linked to longer life in cardiometabolic disease

by

Small Steps, Big Gains: How Everyday Movement Can Transform Health for Millions Even a little bit more activity each day could significantly extend the lives of individuals battling advanced heart, kidney, and metabolic diseases. A groundbreaking new study, published in the Journal of the American Heart Association, reveals that increasing even light physical activity – … Read more

Metabolic syndrome affects nearly four in ten US adults as rates climb in older and Black populations

by

Why Metabolic Syndrome Still Matters in 2024 and Beyond Nearly four out of ten U.S. adults meet the clinical definition of metabolic syndrome—a cluster of conditions that dramatically raises the risk of heart disease, stroke, and type 2 diabetes. While the overall national prevalence appears stable, new data reveal widening gaps among older adults and Black … Read more

AI-based tool may help personalize the treatment of patients with reduced coronary blood flow

by

AI‑Powered CT‑Derived FFR: A New Frontier in Stable Coronary Artery Disease Management When a patient walks into a clinic with chest discomfort that flares during exertion, the classic mantra has been “rule out blockages, then decide on treatment.” Today that mantra is evolving thanks to an artificial‑intelligence (AI) tool that reads coronary computed tomography angiography … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]